Investors in the Malvern biopharmaceutical company include Silicon Valley Bank.
{iframe}https://www.bizjournals.com/philadelphia/news/2017/11/30/phasebio-silicon-valley-bank-medimmune-hypertensio.html{/iframe}
PhaseBio secures $15.6M to advance pipeline – Philadelphia Business Journal